US2010197637A1PendingUtilityA1
Method of Treatment Using Bisphosphonic Acid
Est. expiryMay 10, 2022(expired)· nominal 20-yr term from priority
A61P 19/00A61P 19/10A61P 19/06A61P 19/08A61K 9/2054A61K 9/2018A61K 31/663A61K 31/675A61K 9/2866A61K 31/662
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention refers to a pharmaceutical composition of a bisphosphonic acid or salt thereof, and an excipient thereof, and a method of treating disorder characterized by pathologically increased bone resorption comprising orally administering at least 150% of the expected efficious daily dose of a bisphosphonic acid or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients thereof and administering the dose at a period of one two or three consecutive days per month.
Claims
exact text as granted — not AI-modified1 . A method for treating or preventing disorders characterized by pathologically increased bone resorption comprising orally administering at least 150% of the expected efficacious daily dose of a bisphosphonic acid or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients thereof at a period of one, two or three consecutive days per month.
Join the waitlist — get patent alerts
Track US2010197637A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.